252 related articles for article (PubMed ID: 21422164)
1. Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking.
Milan-Lobo L; Whistler JL
J Pharmacol Exp Ther; 2011 Jun; 337(3):868-75. PubMed ID: 21422164
[TBL] [Abstract][Full Text] [Related]
2. Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism.
Milan-Lobo L; Enquist J; van Rijn RM; Whistler JL
PLoS One; 2013; 8(3):e58362. PubMed ID: 23554887
[TBL] [Abstract][Full Text] [Related]
3. Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes.
Derouiche L; Pierre F; Doridot S; Ory S; Massotte D
Molecules; 2020 Sep; 25(19):. PubMed ID: 33007971
[TBL] [Abstract][Full Text] [Related]
4. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor.
Margolis EB; Fujita W; Devi LA; Fields HL
Neuropharmacology; 2017 Sep; 123():420-432. PubMed ID: 28645621
[TBL] [Abstract][Full Text] [Related]
5. Mu and Delta Opioid Receptors Are Coexpressed and Functionally Interact in the Enteric Nervous System of the Mouse Colon.
DiCello JJ; Carbone SE; Saito A; Rajasekhar P; Ceredig RA; Pham V; Valant C; Christopoulos A; Veldhuis NA; Canals M; Massotte D; Poole DP
Cell Mol Gastroenterol Hepatol; 2020; 9(3):465-483. PubMed ID: 31759144
[TBL] [Abstract][Full Text] [Related]
6. Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation.
He SQ; Zhang ZN; Guan JS; Liu HR; Zhao B; Wang HB; Li Q; Yang H; Luo J; Li ZY; Wang Q; Lu YJ; Bao L; Zhang X
Neuron; 2011 Jan; 69(1):120-31. PubMed ID: 21220103
[TBL] [Abstract][Full Text] [Related]
7. Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons.
He XJ; Patel J; Weiss CE; Ma X; Bloodgood BL; Banghart MR
Elife; 2021 Nov; 10():. PubMed ID: 34787079
[TBL] [Abstract][Full Text] [Related]
8. FBNTI, a DOR-Selective Antagonist That Allosterically Activates MOR within a MOR-DOR Heteromer.
Akgün E; Lunzer MM; Tian D; Ansonoff M; Pintar J; Bruce D; Hawkinson JE; Wilcox GL; Portoghese PS
Biochemistry; 2021 May; 60(18):1413-1419. PubMed ID: 32930576
[TBL] [Abstract][Full Text] [Related]
9. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
[TBL] [Abstract][Full Text] [Related]
10. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
Wang Q; Traynor JR
Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
[TBL] [Abstract][Full Text] [Related]
11. Opiate antagonist prevents μ- and δ-opiate receptor dimerization to facilitate ability of agonist to control ethanol-altered natural killer cell functions and mammary tumor growth.
Sarkar DK; Sengupta A; Zhang C; Boyadjieva N; Murugan S
J Biol Chem; 2012 May; 287(20):16734-47. PubMed ID: 22451667
[TBL] [Abstract][Full Text] [Related]
12. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons.
Haberstock-Debic H; Wein M; Barrot M; Colago EE; Rahman Z; Neve RL; Pickel VM; Nestler EJ; von Zastrow M; Svingos AL
J Neurosci; 2003 May; 23(10):4324-32. PubMed ID: 12764121
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.
Wang Q; Traynor JR
J Biol Chem; 2011 Mar; 286(10):7854-7864. PubMed ID: 21209077
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions.
Law PY; Erickson-Herbrandson LJ; Zha QQ; Solberg J; Chu J; Sarre A; Loh HH
J Biol Chem; 2005 Mar; 280(12):11152-64. PubMed ID: 15657030
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.
Li G; Low PS
Bioorg Med Chem Lett; 2017 May; 27(9):2074-2078. PubMed ID: 28291693
[TBL] [Abstract][Full Text] [Related]
16. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
Chakrabarti S; Yang W; Law PY; Loh HH
Mol Pharmacol; 1997 Jul; 52(1):105-13. PubMed ID: 9224819
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.
Bender AM; Clark MJ; Agius MP; Traynor JR; Mosberg HI
Bioorg Med Chem Lett; 2014 Jan; 24(2):548-51. PubMed ID: 24365161
[TBL] [Abstract][Full Text] [Related]
18. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
19. Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.
Brissett DI; Whistler JL; van Rijn RM
Eur J Pain; 2012 Mar; 16(3):327-37. PubMed ID: 22337177
[TBL] [Abstract][Full Text] [Related]
20. Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands.
Healy JR; Bezawada P; Griggs NW; Devereaux AL; Matsumoto RR; Traynor JR; Coop A; Cunningham CW
Bioorg Med Chem Lett; 2017 Feb; 27(3):666-669. PubMed ID: 28011222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
